SEC Form 4 · accession 0001179110-15-006732
ST JUDE MEDICAL, LLC · STJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric S Fain
Officer — Group President
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000203077
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 24, 2015 | M | 47,000 | $40.55 | A | 122,585 | D | |
| Common StockF3 | Apr 24, 2015 | S | 45,900 | $73.83 | D | 76,685 | D | |
| Common StockF4 | Apr 24, 2015 | S | 1,100 | $74.14 | D | 75,585 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F5 | $40.55 | Apr 24, 2015 | M | 47,000 | D | Dec 10, 2008 | Dec 10, 2015 | Common Stock | 47,000 | 0 | D |
Explanation of responses
- F1The total includes 432 additional shares acquired through the Company Employee Stock Purchase Plan on 7/31/14.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 6, 2015.
- F3The price in Column 4 is a weighted average. The prices actually received ranged from $73.08 to $74.08. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The price in Column 4 is a weighted average. The prices actually received ranged from $74.09 to $74.16. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5Fully vested at the time of filing.